BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Conditions
- Hepatic Encephalopathy
- Decompensated Cirrhosis
- Minimal Hepatic Encephalopathy
Interventions
- DRUG: Oral Branched chain Amino acid
- DRUG: Rifaximin 550 MG
- DRUG: Lactulose
- DRUG: Placebo for BCAA
- DRUG: Placebo for Rifaximin 550mg
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Collaborators